Psychiatry Medical News about Schizophrenia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sensory Contributions to Impaired Emotion Processing in Schizophrenia
Schizophrenia Bulletin, 10/06/09

Butler PD et al. – The results provide evidence for a contribution of impaired early–stage visual processing in emotion recognition deficits in schizophrenia and suggest that a bottom–up approach to remediation may be effective.

<< Previous
The relationship between major depression and marital disruption...

Next >>
Psychotherapeutic interventions in learning disability: focus on...

Today in Neuropsych Sciences...keeping you current

Impulsivity, personality and bipolar disorder
European Psychiatry , 11/06/09

The role of dopamine in bipolar disorder
Bipolar Disorders, 11/18/09

Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis
Journal of Psychiatric Research, 11/20/09

See All of Neuropsych Sciences

Today in Other Psychiatry...keeping you current

Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09

Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09

See All of Other Psychiatry

Today in Schizophrenia/Psychosis...keeping you current

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09

Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder
Schizophrenia Research, 11/18/09

Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate
Asian Journal of Psychiatry, 11/09/09

See All of Schizophrenia/Psychosis

Sponsor

Article Search